InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Gangolli Julian S, 董事. Director active across 2 companies, notably Revance Therapeutics, Inc.. Aggregated, 6 reports have been published. History available since 5 May 2021. The latest transaction was disclosed on 4 February 2025 (U). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Gangolli Julian S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
30,106 股@ US$3.65100.0% 占其流量Common StockSEC:0000950170-25-015688:0
20,000 股@ US$22.75100.0% 占其流量Common StockSEC:0001532023-24-000008:0
15,000 股0Common StockSEC:0001479290-24-000086:0
3,534 股0Common StockSEC:0001479290-23-000064:0
6,059 股0Common StockSEC:0001479290-22-000061:0
4,013 股0Common StockSEC:0001479290-21-000108:0
6 条申报中的 6 条
About Gangolli Julian S
Julian S. Gangolli serves as a Board Member at Revance Therapeutics, Inc. He contributes to the governance of the company by bringing his expertise in strategy and business development. His role is crucial in guiding strategic decisions and ensuring the growth of the organization.
